This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
LifeSpan Biosciences
product type :
protein
product name :
Human CD8A / CD8 Alpha Protein (Recombinant 6His, N-terminus) (Ser22-Asp182) - LS-G26502
catalog :
LS-G26502
product information
ProteinId :
26502
CatalogNumber :
LS-G26502
Product Name :
Human CD8A / CD8 Alpha Protein (Recombinant 6His, N-terminus) (Ser22-Asp182) - LS-G26502
Description :
Recombinant human CD8a protein derived from E.coli
PresentationDesc :
Lyophilized from a sterile solution in 10 mM Tris-HCl, pH 8.0, 100 mM NaH2PO4, 1000 mM imidazole, 6 M Urea.
ProteinTag :
6His, N-terminus
ProteinType :
Recombinant
ProteinSpecies :
Human
ProteinSourceSpecies :
E. coli
RecommendedStorage :
Store at 4°C for frequent use, or aliquot and store at -20°C to -80°C for up to 1 year. Avoid freeze-thaw cycles.
Purification :
Greater than 95% by SDS-PAGE
PredictedMolecularWeight :
19.8 kDa
Gene :
CD8A / CD8 Alpha
StandardGeneSymbol :
CD8A
Synonyms :
CD8A, CD8a molecule, CD8a antigen, OKT8 T-cell antigen, Leu2 T-lymphocyte antigen, T8 T-cell antigen, T cell co-receptor, p32, CD8, Leu2, T-cell antigen Leu2
ShippingInstruction :
+4°C Ice Packs
SalesRegion :
Worldwide
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
CustomerSupport@lsbio.com
https://www.lsbio.com
1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.